Cargando…
1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections
BACKGROUND: Infections complicate approximately 10% of ventriculoperitoneal (VP) shunts in children, with considerable associated morbidity and mortality. Recent guidelines for empiric treatment of VP shunt infections recommend use of vancomycin combined with an anti-pseudomonal beta-lactam, but are...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678182/ http://dx.doi.org/10.1093/ofid/ofad500.1158 |
_version_ | 1785150302050058240 |
---|---|
author | Claunch, Kevin M Adams, Daniel Deperrior, Sarah Rajnik, Michael |
author_facet | Claunch, Kevin M Adams, Daniel Deperrior, Sarah Rajnik, Michael |
author_sort | Claunch, Kevin M |
collection | PubMed |
description | BACKGROUND: Infections complicate approximately 10% of ventriculoperitoneal (VP) shunts in children, with considerable associated morbidity and mortality. Recent guidelines for empiric treatment of VP shunt infections recommend use of vancomycin combined with an anti-pseudomonal beta-lactam, but are based on low-quality evidence. We aimed to further characterize and update the microbiology of pediatric VP shunt infections using the U.S. Military Health System database. METHODS: Department of Defense beneficiaries less than 22 years-of-age admitted for VP shunt infection between Oct 1, 2008 and Sep 30, 2019 were included. VP shunt infection was defined using a combination of ICD-9-CM and ICD-10-CM codes, CPT codes for removal or replacement of a shunt (Table 1), and positive cultures from a normally sterile site (cerebrospinal fluid, blood, catheter tip, and peritoneum). Demographic data on age, sex, and year of admission were collected for each patient, as was microbiologic data including organism and specimen source. [Figure: see text] RESULTS: There were 32 qualifying admissions among 30 patients for VP shunt infection over the 10-year study period, with no discernable year-to-year trend identified. Half of all VP shunt infections occurred in patients less than 12 months of age (Table 2). Sixty-one unique positive cultures were identified among the 30 patients, 38 (62%) from CSF samples, and the remaining 23 (38%) from blood, peritoneum, and catheter tips (Figure 1). Coagulase-negative Staphylococcus (28%), Staphylococcus aureus (15%), and Enterococcus spp. (10%) were the leading causative pathogens (Figure 2). Enteric gram-negative rods accounted for 21% of positive cultures. Pseudomonas spp. were rarely isolated (3%), however, strict anaerobic pathogens made up 8% of positive cultures. [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: Empiric antibiotic treatment of VP shunt infections in children should cover gram-positive cocci and enteric gram-negative rods but need not cover Pseudomonas spp. Existing guidelines do not recommend anaerobic coverage, however, these data indicate empiric anaerobic coverage is prudent, especially when an intra-abdominal VP shunt infection is suspected. DISCLOSURES: All Authors: No reported disclosures |
format | Online Article Text |
id | pubmed-10678182 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-106781822023-11-27 1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections Claunch, Kevin M Adams, Daniel Deperrior, Sarah Rajnik, Michael Open Forum Infect Dis Abstract BACKGROUND: Infections complicate approximately 10% of ventriculoperitoneal (VP) shunts in children, with considerable associated morbidity and mortality. Recent guidelines for empiric treatment of VP shunt infections recommend use of vancomycin combined with an anti-pseudomonal beta-lactam, but are based on low-quality evidence. We aimed to further characterize and update the microbiology of pediatric VP shunt infections using the U.S. Military Health System database. METHODS: Department of Defense beneficiaries less than 22 years-of-age admitted for VP shunt infection between Oct 1, 2008 and Sep 30, 2019 were included. VP shunt infection was defined using a combination of ICD-9-CM and ICD-10-CM codes, CPT codes for removal or replacement of a shunt (Table 1), and positive cultures from a normally sterile site (cerebrospinal fluid, blood, catheter tip, and peritoneum). Demographic data on age, sex, and year of admission were collected for each patient, as was microbiologic data including organism and specimen source. [Figure: see text] RESULTS: There were 32 qualifying admissions among 30 patients for VP shunt infection over the 10-year study period, with no discernable year-to-year trend identified. Half of all VP shunt infections occurred in patients less than 12 months of age (Table 2). Sixty-one unique positive cultures were identified among the 30 patients, 38 (62%) from CSF samples, and the remaining 23 (38%) from blood, peritoneum, and catheter tips (Figure 1). Coagulase-negative Staphylococcus (28%), Staphylococcus aureus (15%), and Enterococcus spp. (10%) were the leading causative pathogens (Figure 2). Enteric gram-negative rods accounted for 21% of positive cultures. Pseudomonas spp. were rarely isolated (3%), however, strict anaerobic pathogens made up 8% of positive cultures. [Figure: see text] [Figure: see text] [Figure: see text] CONCLUSION: Empiric antibiotic treatment of VP shunt infections in children should cover gram-positive cocci and enteric gram-negative rods but need not cover Pseudomonas spp. Existing guidelines do not recommend anaerobic coverage, however, these data indicate empiric anaerobic coverage is prudent, especially when an intra-abdominal VP shunt infection is suspected. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10678182/ http://dx.doi.org/10.1093/ofid/ofad500.1158 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Claunch, Kevin M Adams, Daniel Deperrior, Sarah Rajnik, Michael 1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections |
title | 1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections |
title_full | 1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections |
title_fullStr | 1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections |
title_full_unstemmed | 1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections |
title_short | 1319. Microbiology and Epidemiology of Pediatric Ventriculoperitoneal Shunt Infections |
title_sort | 1319. microbiology and epidemiology of pediatric ventriculoperitoneal shunt infections |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678182/ http://dx.doi.org/10.1093/ofid/ofad500.1158 |
work_keys_str_mv | AT claunchkevinm 1319microbiologyandepidemiologyofpediatricventriculoperitonealshuntinfections AT adamsdaniel 1319microbiologyandepidemiologyofpediatricventriculoperitonealshuntinfections AT deperriorsarah 1319microbiologyandepidemiologyofpediatricventriculoperitonealshuntinfections AT rajnikmichael 1319microbiologyandepidemiologyofpediatricventriculoperitonealshuntinfections |